Endosaccular Flow Disruption Device market

Endosaccular Flow Disruption Device Market, Global Outlook and Forecast 2022-2028

  • 19 October 2022
  • Life Sciences
  • 72 Pages
  • Report code : PMR-7450002

  • 4.7 (158)

Endosaccular Flow Disruption Device Market

Download FREE Report Sample

  Download Free sample

Endosaccular flow disruption is an innovative method of treating wide-necked complex aneurysms. Currently four types of devices have obtained the CE mark for use within Europe. These are the Woven EndoBridge device (WEB), the Luna Aneurysm Embolization System, the Medina Embolic Device (Medtronic), and the Contour Neurovascular System.
Endosaccular Flow Disruption Device Market contains market size and forecasts of Endosaccular Flow Disruption Device in global, including the following market information:
Global Endosaccular Flow Disruption Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Endosaccular Flow Disruption Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Endosaccular Flow Disruption Device companies in 2021 (%)
The global Endosaccular Flow Disruption Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cylindrical Construct Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Endosaccular Flow Disruption Device include MicroVention (WEB), Cerus Endovascular (Contour Neurovascular System), Medtronic (Medina Embolic Device, Luna Aneurysm Embolization System) and Phenox GmbH (pCONUS?, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Endosaccular Flow Disruption Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Endosaccular Flow Disruption Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Endosaccular Flow Disruption Device Market Segment Percentages, by Type, 2021 (%)
Cylindrical Construct
Spherical Construct
Global Endosaccular Flow Disruption Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Endosaccular Flow Disruption Device Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Others
Global Endosaccular Flow Disruption Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Endosaccular Flow Disruption Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Endosaccular Flow Disruption Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Endosaccular Flow Disruption Device revenues share in global market, 2021 (%)
Key companies Endosaccular Flow Disruption Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Endosaccular Flow Disruption Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
MicroVention (WEB)
Cerus Endovascular (Contour Neurovascular System)
Medtronic (Medina Embolic Device, Luna Aneurysm Embolization System)
Phenox GmbH (pCONUS?

CHECK TODAYS BEST PRICE

BEST PRICE: $2275
Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Endosaccular Flow Disruption Device Market

Leave This Empty: